File(s) under permanent embargo

Reason: Restricted by author. A copy can be supplied under Section 51 (2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library, or by emailing document.delivery@monash.edu

Role of Wnt pathway dysregulation in Multiple Myeloma (MM)

thesis
posted on 12.04.2017, 02:28 by Ioanna Savvidou
MM is a highly heterogeneous and incurable disease. Available evidence suggests that the Wnt/canonical pathway contributes to both disease progression and drug resistance confirming the pathway as an attractive potential therapeutic target. Wnt/β-catenin up-regulation can be the result of multiple factors, which in solid tumour can co-exist, all further enhancing pathway activity. Moreover, we identified a possible additional mechanism relating to the receptor complex expression. Among a variety of Wnt/canonical pathway inhibitors that we tested, BC2059 was shown to have the best anti-MM results in clinically feasible doses, with a favourable in vivo toxicity profile. In the era of combinational chemotherapy BC2059 also proved to exert significant synergistic anti-MM effect both in combination with well-established and novel anti-MM drugs, warranting further investigation. Finally, exploring in more detail the cytotoxic and pro-survival effect of BC2059 we were able to identify that inhibition of autophagy was able to amplify its anti-MM effect. This approach may represent a new paradigm for enhancing the activity of established or novel anti-MM regimens.

History

Principal supervisor

Andrew Spencer

Additional supervisor 1

Tiffany Khong

Year of Award

2017

Department, School or Centre

Clinical Haematology (Australian Centre for Blood Diseases)

Campus location

Australia

Faculty

Faculty of Medicine Nursing and Health Sciences

Usage metrics

Categories

Exports